Law, A., Pilon, D., Lynen, R., Laliberté, F., Gozalo, L., Lefebvre, P., & Duh, M. (2016). PMD71 - IMPACT OF THE INTRODUCTION OF NEWER LONG ACTING REVERSIBLE CONTRACEPTIVE (LARC) METHODS ON LARC USE IN A COMMERCIALLY INSURED POPULATION. Value in Health, 19(3), A309. https://doi.org/10.1016/j.jval.2016.03.675
Chicago Style (17th ed.) CitationLaw, A., D. Pilon, R. Lynen, F. Laliberté, L. Gozalo, P. Lefebvre, and M.S Duh. "PMD71 - IMPACT OF THE INTRODUCTION OF NEWER LONG ACTING REVERSIBLE CONTRACEPTIVE (LARC) METHODS ON LARC USE IN A COMMERCIALLY INSURED POPULATION." Value in Health 19, no. 3 (2016): A309. https://doi.org/10.1016/j.jval.2016.03.675.
MLA (9th ed.) CitationLaw, A., et al. "PMD71 - IMPACT OF THE INTRODUCTION OF NEWER LONG ACTING REVERSIBLE CONTRACEPTIVE (LARC) METHODS ON LARC USE IN A COMMERCIALLY INSURED POPULATION." Value in Health, vol. 19, no. 3, 2016, p. A309, https://doi.org/10.1016/j.jval.2016.03.675.